D03.112
Melanoma in situ of right lower eyelid, including canthus
Clinical Classification Guidelines
Medical Intelligence & Overview
Melanoma in situ of the right lower eyelid, including the canthus, is a type of early-stage skin cancer confined to the outermost layer of skin. Specifically affecting the eyelid area on the right side, this condition is an important diagnosis that requires attention to prevent progression. 'In situ' indicates that the cancer cells have not invaded deeper tissues, offering a good chance for successful treatment if detected early. The eyelid's delicate skin and proximity to the eye make timely diagnosis and management critical for preserving eye function and appearance.
Causes & Symptoms
Clinical Causes: Excessive exposure to ultraviolet (UV) radiation from sunlight or tanning beds. History of sunburns or frequent sun exposure in childhood. Fair skin, light hair, and light eye color, which increase susceptibility. Presence of existing pigmented lesions or atypical moles on the eyelid area. Genetic factors and family history of skin cancers. Immunosuppression, such as from certain medical treatments or conditions.
Key Symptoms: A new, unusual pigmented spot or lesion on the eyelid that changes in appearance over time. Irregular borders or uneven pigmentation in a pigmented lesion. A lesion that is raised or palpable upon examination. Persistence of a pigmented area that does not heal or resolves and then reappears. Presence of small, dark patches near the eyelid or canthus. Unexplained changes in existing beauty marks or moles located around the eyelid.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of melanoma in situ involves a thorough clinical examination by a healthcare professional, focusing on any suspicious pigmented lesions. Confirmation typically requires a biopsy, where a small tissue sample from the lesion is examined microscopically for cancerous cells. In some cases, imaging studies may be used to evaluate the local extent of the lesion and rule out deeper invasion. The specific location on the eyelid and canthus necessitates careful mapping and consideration during diagnosis.
Treatment Protocols: Treatment options for melanoma in situ of the eyelid include:
Clinical Advice & FAQs
Billing Guidance
Is D03.112 a billable ICD-10 code?
Yes, D03.112 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D03.112?
Clinical documentation must specify the nature of Melanoma in situ of right lower eyelid, including canthus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference